A phase 2, controlled, multi-center pilot study to evaluate the efficacy and safety of Deligoparin in subjects with retinal vein occlusion of recent onset.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-003374-24-IT

Enrollment

Registered

2005-08-11

Start date

2005-09-12

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of retinal vein occlusion. MedDRA version: 6.1 Level: PT Classification code 10038907

Interventions

Product Name: Deligoparin Product Code: NA Pharmaceutical Form: Solution for injection CAS Number: NA Current Sponsor code: NA Other descriptive name: NA Concentration unit: mg milligram(s) Concentrat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026